HTA
CVS icon

Haber Trilix Advisors’s CVS Health CVS Stock Holding History

Haber Trilix Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$7.62M Buy
+133,290
New +$7.72M 0.95% 30

Other funds holding CVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return

Haber Trilix Advisors's CVS Position: Q2 2013 in Review

Haber Trilix Advisors opened a new position in CVS Health (CVS) in Q2 2013: 133,290 shares worth $7.62M. The stake represents 0.95% of the portfolio and ranks #30 among its holdings.

1,107 funds tracked by Wall St. Rank hold CVS as of Q2 2013.

  • Haber Trilix Advisors held 133,290 shares of CVS Health worth $7.62M as of Q2 2013.
  • CVS Health was a new Haber Trilix Advisors position in Q2 2013.
  • CVS Health made up 0.95% of Haber Trilix Advisors's portfolio in Q2 2013, its #30 holding.
  • 1,107 funds tracked by Wall St. Rank held CVS Health as of Q2 2013.

Based on Haber Trilix Advisors's 13F filing for Q2 2013, filed 14 Aug 2013.